Using lessons learned for BRCA testing and marketing: what lies ahead for whole genome scanning services
McGowan, Michelle L.
Fishman, Jennifer R.
American Journal of Bioethics 2008 June; 8(6): 18-20
Showing items related by title, author, creator and subject.
Matloff, Ellen; Caplan, Arthur (2008-06)Myriad Genetics holds a patent on testing for the hereditary breast and ovarian cancer genes, BRCA1 and BRCA2, and therefore has a forced monopoly on this critical genetic test. Myriad launched a Direct-to-Consumer (DTC) ...